Proper use of a soft mist inhaler requires that the patient be able to do which of the following?
a. Generate inspiratory flows of 60 L/min or higher.
b. Exhale forcibly through the device before drug delivery.
c. Requires hand-breath coordination on the part of the patient.
d. Connect the device to the proper gas source.
Q. 2 Which of the following would you recommend as initial therapy for a patient admitted to the emergency department with acute airway obstruction (wheezing, cough, dyspnea, peak expirato-ry flow rate PEFR <60 predicted)?
1. Assess dose-response of metered dose inhaler (MDI) albuterol (up to 12 puffs).
2. Provide up to three small-volume jet nebulizer (SVN) treatments with albuterol every 20 min.
3. Immediately begin continuous albuterol therapy at 15 mg/hr.
a. 1 or 2 only
b. 1 or 3 only
c. 2 or 3 only
d. 1, 2, and 3
Q. 3 Indications for assessment of patient's response to bronchodilator therapy include which of the following?
a. Confirm whether the therapy works as intended.
b. Individualize the dose, frequency, or type of medication.
c. Help follow the patient's status during long-term therapy.
d. Quantify the degree of bronchial hyperresponsiveness.
a. 1 and 3 only
b. 1, 2, and 3 only
c. 3 and 4 only
d. 2, 3, and 4 only
Q. 4 Appropriate documentation when conducting point-of-care assessment of a patient's response to bronchodilator therapy includes which of the following?
a. Medication type, dose, and time received
b. Vital signs, breath sounds, and pulmonary function test measures
c. Patient's progress and ability to self-assess symptoms
d. Blood levels of the bronchodilator agent
a. 1 and 2 only
b. 1, 2, and 3 only
c. 3 and 4 only
d. 1, 2, 3, and 4
Q. 5 On the average, what percentage of an aerosol drug delivery device's output actually deposits in the lungs?
a. Less than 10
b. 10
c. 20
d. 30